| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/6/269:00 AM | -$0.13 | -$0.28GAAP | -115% | — | $113.3M | $102.2M | -9.8% | -1% | |
| Q2 '26 | 8/6/267:00 AM | $0.02 | -$0.02GAAP | -200% | +90% | $111.0M | $115.9M | +4.4% | +18% | |
| Q1 '26 | 5/6/267:00 AM | -$0.26 | $0.25GAAP | +196% | +150% | $107.4M | $106.7M | -0.7% | +14% | |
| Q4 '25 | 2/25/267:00 AM | -$0.23 | -$0.60GAAP | -161% | -28% | $107.8M | $104.5M | -3.1% | +24% | |
| Q3 '25 | 11/6/257:00 AM | -$0.26 | $0.00GAAP | +100% | -100% | $101.1M | $103.7M | +2.6% | +29% | |
| Q2 '25 | 8/7/257:00 AM | -$0.21 | -$0.20GAAP | +4.8% | +13% | $92.6M | $98.0M | +5.8% | +30% | |
| Q1 '25 | 5/7/257:00 AM | -$0.41 | $0.10GAAP | +124% | +120% | $86.5M | $93.9M | +8.6% | +33% |
GAAP = diluted EPS as filed with the SEC.